Revolution Medicines, Inc. Balance Sheet
RVMD / Health Care|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Revolution Medicines, Inc. had $2.4B in total assets and $1.6B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383.7M | $543.1M | $696.1M | $108.5M | $104.3M | $16.7M | $16.7M | $69.6M |
| Current Assets | $2.1B | $2.3B | $1.9B | $660.2M | $589.8M | $454.1M | $134.0M | - |
| PP&E (Net) | $33.2M | $24.3M | $22.9M | $18.7M | $11.5M | $8.9M | $7.1M | - |
| Goodwill | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | - |
| Total Assets | $2.4B | $2.6B | $2.1B | $811.9M | $738.0M | $567.4M | $220.5M | - |
| Current Liabilities | $290.4M | $163.9M | $143.9M | $62.0M | $60.4M | $47.2M | $43.1M | - |
| Shareholders' Equity | $1.6B | $2.3B | $1.8B | $474.7M | -$152.6M | -$108.4M | -$152.6M | -$108.4M |